05.11.2014 Views

annual Report 2009 - STRATEC Biomedical AG

annual Report 2009 - STRATEC Biomedical AG

annual Report 2009 - STRATEC Biomedical AG

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

These differences, which are generally temporary, result from the following items in the balance sheet:<br />

in v thousand 12.31.<strong>2009</strong> 12.31.2008<br />

Change through<br />

profit or loss<br />

Change recognized<br />

in equity<br />

Tax loss carryovers 63 0 63 0<br />

Other provisions 9 3 6 0<br />

Financial liabilities 32 0 0 32<br />

Pension provisions 14 14 0 0<br />

Deferred tax ASSETS before consolidation (A) 118 17 69 32<br />

Deferred tax assets from currency<br />

translation of foreign companies 51 6 0 0<br />

Deferred tax assets from elimination of intercompany profits 16 35 16 0<br />

Total deferred tax ASSETS (A) 185 68 85 32<br />

Intangible assets 1,139 657 -284 766<br />

Financial assets 56 57 -1 0<br />

Trade receivables 15 0 15 0<br />

Future receivables from construction contracts 416 340 76 0<br />

Inventories 41 86 -64 19<br />

Deferred tax liabilities from currency<br />

translation of foreign companies 10 9 0 1<br />

Other liabilities and provisions 19 8 11 0<br />

Total deferred tax LIABILITIES (L) 1,696 1,157 -247 786<br />

Net balance of deferred tax liabilities 1,511 1,089 -332 754<br />

The reduction in net tax deferrals through profit or loss in the <strong>2009</strong> financial year (u -329 thousand; previous year:<br />

u -298 thousand) has been recognized in the statement of comprehensive income under “Deferred tax income”.<br />

The costs of capital increases after income taxes (u 2 thousand; previous year: u 2 thousand) have been offset against<br />

the capital reserve.<br />

The change in deferred taxes recognized in equity for intangible assets and significant portions of non-current financial assets<br />

results from the hidden reserves and liabilities identified upon the acquisition of the Invitek subsidiary on April 23, <strong>2009</strong>,<br />

as well as from the currency translation of hidden reserves relating to three software components disclosed in the 2006<br />

financial year upon consolidation of Sanguin International Ltd. and of the shareholding in Sanguin International Inc. (USA)<br />

as of the <strong>2009</strong> balance sheet date compared with the previous year’s balance sheet date. The translation differences<br />

have been allocated net of tax to the currency translation reserve within Group equity (other equity).<br />

88 stratec Annual <strong>Report</strong> <strong>2009</strong>

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!